Abstract:9533 Background: The identification of malignant cells in effusions by conventional cytology is hampered by its limited sensitivity. Previous studies show that the MAGE genes families are only expressed in the malignant cells and not expressed in normal tissues except testis and placenta. The aim of this study was to improve tumor cell detection in effusions by reverse-transcriptase polymerase chain reaction (RT-PCR) for MAGE families expression. Methods: A total of 22 thoracic effusions from patients with lung cancer and 18 thoracic effusions from patients without an evidence of malignancy were included in this study. All effusion specimens were evaluated in parallel by cytology, RT-PCR for MAGE families expression and pleural biopsy under video assisted thoracoscopy. To improve the sensitivity of RT-PCR, we combined the results of RT-PCR for MAGE-1, 2, 3 and 4 expressions. Anyone of them expressed in the effusion was recorded as MAGE positive. Results: Tumor cell detection by cytology, RT-PCR for MAGE expression and pleural biopsy were negative in all of 18 effusions from patients with benign disease. In 22 effusions from patients with lung cancer, the sensitivities of tumor cell detection by cytology, RT-PCR for MAGE expression and pleural biopsy were 36%(8/22), 86%(19/22) and 100%(22/22), respectively. The corresponding specificities were all 100%. All the 8 effusions that were positive in cytology were positive in MAGE expression. Notably, 11 out of 14 effusions that were negative in cytology but positive in pleural biopsy were positive in MAGE expression. For the other 3 malignant effusions that were negative in both cytology and MAGE expression, RT-PCR for MAGE families expression on pleural biopsy samples were also negative which indicated the MAGE were not expressed in these tumors. Conclusions: RT-PCR for MAGE families expression is a highly sensitive and specific diagnostic tool for detecting malignant cells in effusions especially for the cytological negative effusions. No significant financial relationships to disclose.

The Diagnostic Significance of the Detection of Cytokeratin 19 Mrna by Quantitative RT-PCR in Benign and Malignant Pleural Effusions

Combined Detection of Carcinoembryonic Antigen and C-reactive Protein in Identifying Benign and Malignant Pleural Effusion

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Clinical Significance of CK19-2G2,CK18-3A9 and mesothelin assay in diagnosis of pleural effusion

[Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].

Detection of hTERT mRNA , CEA , CA 19-9 in Pleural Effusion and Its

Detection Of Mrnas Of Ga733 Genes By Rt-Pcr In Exfoliated Cells Of Pleural And Peritoneal Effusions And Its Clinical Values

The expression levels of VEGF and ICAM-1 in pleural effusion

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Diagnostic Value of Reverse-Transcriptase Polymerase Chain Reaction for MAGE Families Expression in Malignant Thoracic Pleural Effusions

Study on the correlationship between CK19mRNA and CyFRA21-1 in peripheral blood of lung cancer patients

Clinical Significance of Combined Detection of CEA, CYFRA21-1,CA19-9 and Fer in Differential Diagnosis of Benign Pleural Effusion and Malignant Pleural Effusion

The Detection and Its Clinical Significance of Cytokeratin 19 Mrna (CK19 Mrna) in Pelvic Lymph Nodes of Cervical Cancer Patients

Clinical Value of Qualitative Determination of C-Reactive Protein in the Differential Diagnosis of Benign and Malignant Pleural Effusions or Ascites

The Value of MAGE-3 mRNA Expression in Pleural Effusion in Differential Diagnosis of Benign and Malignant Pleural Effusion

Detection of Cytokeratin 19 Mrna in Peripheral Blood by RT-PCR in Patients with Renal Cell Carcinoma

Detection of Telomerase Activity in Pleural Effusion Cells from Patients with Malignant Neoplasm

The Diagnostic Value of MCP-1 and RANTES in Tuberculosis and Malignant Pleural Effusion

Diagnostic Value of Combined Detection of CYFRA211 and TGF-β_1 in Pleural Effusions

Clinical Significance of Cytokeratin 19 Mrna in the Peripheral Blood of Non-Small Cell Lung Cancer

Detection of Cell-Free BIRC5 Mrna in Effusions and Its Potential Diagnostic Value for Differentiating Malignant and Benign Effusions.